NCT04943627 2022-10-05Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)Agenus Inc.Phase 3 Withdrawn
NCT00369954 2013-06-10Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or CarboplatinGOG FoundationPhase 2 Withdrawn
NCT00057928 2012-06-13S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerSWOG Cancer Research NetworkPhase 3 Withdrawn